Moving research forward
MS in numbers
Prevalence: 400,000 in United States, 2.1 million worldwide |
Multiple sclerosis research is progressing at a remarkable rate, with more potential therapies in the pipeline than at any other time in history. The National Multiple Sclerosis Society is a driving force of MS research and treatment to stop disease progression, restore function and end MS forever.
In 2010, through the national office and 50-state network of chapters, the Society invested $36 million to support 325 research initiatives around the world. Click here to read about how far we've come.
2010: A year of significant progress in MS research
Toward stopping disease progression
Progress was made toward finding better therapies for MS, including the availability of the first oral disease-modifying therapy for MS.
Toward restoring function
Progress was made toward finding ways to repair nervous system damage and in improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first therapy specifically approved to treat a symptom of MS (Ampyra™).
Toward ending MS forever
Understanding of factors that influence whether a person develops MS deepened this year, bringing us closer to finding ways to prevent the disease.
Click here to discover the details of the progress made in MS research in 2010.
What’s ahead
The society has three clear research goals — stop MS, restore function and end MS forever. Click here to read about some intriguing leads on the horizon.
To learn more, visit nationalMSsociety.org/research.